Home  »  Finance   »  Theseus Pharmaceuticals Inc.: Navigating a Turbule...

Theseus Pharmaceuticals Inc.: Navigating a Turbulent Year, Up -44.74% from 52-Week Low

The stock of Theseus Pharmaceuticals Inc. (THRX) is currently priced at $8.16. In the last session, the stock climbed significantly, topping out at $9.1416 after opening at $8.88. The day’s lowest price was $8.435 before the stock closed at $8.72.

The market performance of Theseus Pharmaceuticals Inc.’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $14.77 on 02/06/23, while the lowest value for the same duration was $4.01 on 11/04/22.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.

Sponsored

52-week price history of THRX Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Theseus Pharmaceuticals Inc.’s current trading price is -44.74% away from its 52-week high, while its distance from the 52-week low is 103.49%. The stock’s price range during this period has spanned from $4.01 to $14.77. In the Healthcare sector, the Theseus Pharmaceuticals Inc.’s shares surpassed a trading volume of approximately 0.96 million for the day, which was noticeably higher compared to the average daily volume of 9.0.12 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Theseus Pharmaceuticals Inc. (THRX) has experienced a quarterly decline of -14.47% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 373.04M and boasts a workforce of 38 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.04, with a change in price of +2.80. Similarly, Theseus Pharmaceuticals Inc. recorded 219,468 in trading volume during the last 100 days, posting a change of +53.74%.

Examining THRX’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for THRX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

THRX Stock Stochastic Average

Today’s raw stochastic average for Theseus Pharmaceuticals Inc. over the last 50 days is 15.67%.This indicates a increase from the raw stochastic average of the past 20 days, which was 15.67%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 8.32% and 8.43%, respectively.

THRX Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 63.86% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 21.79%. Over the past 30 days, the price of THRX has leaped by -15.88%. And in the last five days, it has fallen by -25.82%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts